Newswise — (Chatham, NJ – April 9, 2015) Current statistics on U.S. birth rates from the Centers for Disease Control and Prevention (CDC) report a continued trend toward delayed motherhood. As fertility gradually declines in the 30s, particularly after age 35 (1), the risk of experiencing difficulty conceiving may increase. In addition to age, there are other common reasons why women may experience difficulties conceiving, including: irregular ovulation cycles and poor egg quality, which may be associated with stress, lifestyle or poor diet.
“Ideally, women concerned about their ability to conceive may want to explore a natural approach before they opt for medical therapies, artificial insemination or assisted reproductive technology,” said Dr. Georgianna Donadio, Director of the Boston-based National Institute of Whole Health. A pioneer in the fields of Whole Person Health Care and Behavioral Health, Dr. Donadio established the National Institute of Whole Health in 1977 and has helped to lead the transformation of health care towards the Whole Health movement.
Multiple research studies report that taking a combination of myo-inositol, which is a naturally occurring substance produced by the human body from glucose, and folic acid, a B vitamin that promotes cell growth – in therapeutic doses - promotes menstrual regularity, ovulatory function and higher quality eggs. Myo-inositol and folic acid are the ingredients in Pregnitude®, a doctor recommended dietary supplement for reproductive health.
Mounting Clinical Evidence.
More than a half dozen clinical trials over the past decade have evaluated the effects of myo- inositol combined with folic acid on women. Published research includes a randomized, double- blind study by Gerli et al., which compared results for women taking myo-inositol and folic acid, versus women taking only folic acid. The study found that women taking both myo-inositol and folic acid ovulated more quickly and more frequently. In another example of published research, a randomized, double-blind study by Ciotta et al. found that women taking myo-inositol and folic acid had greater numbers of follicles of a desirable size and produced significantly more oocyte eggs than women taking only folic acid. (2,3)
"Consumers have had very positive responses about Pregnitude," said Maria Carell, CEO of Exeltis USA, the U.S. distributor of Pregnitude. "The fact that Pregnitude is generally well tolerated is also reassuring to both women and their doctors," adds Ms. Carell.
Pregnitude is available without a prescription through pharmacy and online retailers, including: Walgreens.com, Drugstore.com, Pregnitude.com, Amazon.com and Earthsmagic.com. For more information, visit: http://www.pregnitude.com
About Exeltis USA
Exeltis USA (formerly Everett Laboratories) is committed to improving women’s health at all stages of life (contraception, pregnancy, fertility and menopause) and offers an extensive portfolio of products to meet women’s reproductive health needs and help improve wellbeing and quality of life. For more information: http://womenshealth.exeltisusa.com/
References:1. American Society of Reproductive Medicine www.asrm.org
2. Randomized, double-blind placebo-controlled trial: Effects of Myo-inositol on Ovarian Function and Metabolic Factors in Women with PCOS; S Gerli et al: European Review for Medical and Pharmacological Sciences, 2007.
3. Effects of Myo-inositol Supplementation on Oocytes Quality in PCOS Patients: A Double- blind Trial; L. Ciotta et al: European Review for Medical and Pharmacological Sciences, 2011
The statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
RSS